Lightwave Logic Introduces New Prototype Phase Modulator at Gilder/Forbes Telecosm Conference, NY

Lightwave Logic, Inc. (OTC Bulletin Board: LWLG) a technology company focused on the development of the 'Next Generation Electro-Optic Polymer Material Platform' for applications in high speed fiber-optic telecommunications and optical computing, today announced that Terry Turpin, Lightwave's Optical Computing Guru, introduced Lightwave's new prototype phase modulator to the Gilder/Forbes Telecosm Conference in Tarrytown, New York earlier this week.

The Gilder/Forbes Telecosm Conference is an annual event that offers investors, executives, engineers and entrepreneurs an elite analysis of ascending and disruptive technologies affecting management and investment decisions.

Mr. Turpin, who participated in a panel on improving storage and processing with 3D stacks of silicon chips, informed the conference attendees that "Lightwave's material could be spun onto silicon chips prior to stacking and used for input, output, and interconnect due to the stability of Lightwave's electro-optic polymer and Lightwave's recent demonstration that its proprietary Perkinamine material can survive all of the rigors of standard commercial manufacturing processes." Other applications Mr. Turpin discussed with the conference attendees included low cost modulators for fiber optic communications, multi-channel modulators for ultra dense wavelength division multiplex systems, and optical computing. Mr. Turpin remarked "Lightwave's technology is inherently low cost, which is an attractive quality that should assure acceptance in an extremely cost sensitive market." The talk was warmly received and the prototype generated significant interest in Lightwave's technology.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.